ConductScience.org, home

Paper30770534

A Dose-finding Study of a Wild-type Influenza A(H3N2) Virus in a Healthy Volunteer Human Challenge Model.

Han A and 10 others. Clin Infect Dis, 2019. Cited by 58 papers, by iCite.

Cite this record

ConductScience Library. A Dose-finding Study of a Wild-type Influenza A(H3N2) Virus in a Healthy Volunteer Human Challenge Model. Papers, record 30770534. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30770534

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A Dose-finding Study of a Wild-type Influenza A(H3N2) Virus in a Healthy Volunteer Human Challenge Model.
PubMed
Journal
Clin Infect Dis
PubMed
Year
2019
PubMed
Publication types
Journal Article, Research Support, N.I.H., Intramural
PubMed
Citations, by iCite
58
iCite
Relative citation ratio, by iCite
2.47
iCite
Revised in PubMed
2021-04-27
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Han AAlison
2Czajkowski LMLindsay M
3Donaldson AAmanda
4Baus HAHolly Ann
5Reed SMSusan M
6Athota RSRani S
7Bristol TTyler
8Rosas LALuz Angela
9Cervantes-Medina AAdriana
10Taubenberger JKJeffery K
11Memoli MJMatthew J

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Influenza A Virus, H3N2 SubtypeMajor topic
Influenza VaccinesMajor topic
Influenza, HumanMajor topic
VaccinationMajor topic
Adolescent
Adult
Antibodies, Viral
Female
Healthy Volunteers
Humans
Immunization Schedule
Male
Middle Aged
Virus Shedding
Young Adult

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
ZIAAI000986NIHNIH RePORTER
ZIAAI001157NIHNIH RePORTER

Download CSV of grants

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT02594189Influenza A H3N2 Human Challenge Study in Healthy Adult VolunteersDerived from the trialYes

Source ClinicalTrials.gov

Download CSV of trials

Comments and corrections2

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn PapersSource
Comment in32206777Reply to Bernstein, Atmar, and Hoft.https://conductscience.org/library/papers/32206777PubMed
Comment in32206804Influenza Challenge Models: Ready for Prime Time?https://conductscience.org/library/papers/32206804PubMed

Download CSV of comments and corrections

References35

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129506129A Universal Influenza Vaccine: The Strategic Plan for the National Institute of Allergy and Infectious Diseases.J Infect Dis2018https://conductscience.org/library/papers/29506129PubMed
217942553The influenza virus resource at the National Center for Biotechnology Information.J Virol2008https://conductscience.org/library/papers/17942553PubMed
330055573Using the Influenza Patient-reported Outcome (FLU-PRO) diary to evaluate symptoms of influenza viral infection in a healthy human challenge model.BMC Infect Dis2018https://conductscience.org/library/papers/30055573PubMed
416384583An epidemiologically significant epitope of a 1998 human influenza virus neuraminidase forms a highly hydrated interface in the NA-antibody complex.J Mol Biol2006https://conductscience.org/library/papers/16384583PubMed
53336068Four viral genes independently contribute to attenuation of live influenza A/Ann Arbor/6/60 (H2N2) cold-adapted reassortant virus vaccines.J Virol1988https://conductscience.org/library/papers/3336068PubMed
629477403Reliability, Validity, and Responsiveness of InFLUenza Patient-Reported Outcome (FLU-PRO©) Scores in Influenza-Positive Patients.Value Health2018https://conductscience.org/library/papers/29477403PubMed
719427959The Bill & Melinda Gates Foundation's grant-making programme for global health.Lancet2009https://conductscience.org/library/papers/19427959PubMed
82712549Efficacy and safety of low dosage amantadine hydrochloride as prophylaxis for influenza A.Antiviral Res1989https://conductscience.org/library/papers/2712549PubMed
924898165Influenza activity - United States, 2013-14 season and composition of the 2014-15 influenza vaccines.MMWR Morb Mortal Wkly Rep2014https://conductscience.org/library/papers/24898165PubMed
1028662019Update: Influenza Activity in the United States During the 2016-17 Season and Composition of the 2017-18 Influenza Vaccine.MMWR Morb Mortal Wkly Rep2017https://conductscience.org/library/papers/28662019PubMed
1125416753Validation of the wild-type influenza A human challenge model H1N1pdMIST: an A(H1N1)pdm09 dose-finding investigational new drug study.Clin Infect Dis2015https://conductscience.org/library/papers/25416753PubMed
1226042650Influenza activity - United States, 2014-15 season and composition of the 2015-16 influenza vaccine.MMWR Morb Mortal Wkly Rep2015https://conductscience.org/library/papers/26042650PubMed
1320090904Conservation and diversity of influenza A H1N1 HLA-restricted T cell epitope candidates for epitope-based vaccines.PLoS One2010https://conductscience.org/library/papers/20090904PubMed
142182673Use of live cold-adapted influenza A H1N1 and H3N2 virus vaccines in seropositive adults.J Clin Microbiol1990https://conductscience.org/library/papers/2182673PubMed
157141686Live influenza A/Victoria/75 (H3N2) virus vaccines: reactogenicity, immunogenicity, and protection against wild-type virus challenge.Infect Immun1982https://conductscience.org/library/papers/7141686PubMed
1629045889The Pathway to a Universal Influenza Vaccine.Immunity2017https://conductscience.org/library/papers/29045889PubMed
173711273Evaluation of live avian-human reassortant influenza A H3N2 and H1N1 virus vaccines in seronegative adult volunteers.J Clin Microbiol1986https://conductscience.org/library/papers/3711273PubMed
1827281364Influenza Activity - United States, 2015-16 Season and Composition of the 2016-17 Influenza Vaccine.MMWR Morb Mortal Wkly Rep2016https://conductscience.org/library/papers/27281364PubMed
196143042Advantage of live attenuated cold-adapted influenza A virus over inactivated vaccine for A/Washington/80 (H3N2) wild-type virus infection.Lancet1984https://conductscience.org/library/papers/6143042PubMed
2029566007Performance of the inFLUenza Patient-Reported Outcome (FLU-PRO) diary in patients with influenza-like illness (ILI).PLoS One2018https://conductscience.org/library/papers/29566007PubMed

See all 35 referencesDownload CSV of references

Cited by49

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 58 citations.

PMIDTitleJournalYearIn PapersSource
42972013Towards anti-influenza nasal sprays: infection models and opportunities to reduce animal testing.Npj Viruses2026https://conductscience.org/library/papers/42972013PubMed
42803584From viral infection to emission: host barriers shaping airborne transmission.J Virol2026https://conductscience.org/library/papers/42803584PubMed
42437685Hemagglutination Inhibition and Alternate Serologic Responses Following Influenza A(H3N2) Virus Infection.Influenza Other Respir Viruses2026https://conductscience.org/library/papers/42437685PubMed
42188797A Human Mobility-Based Modeling Study of Influenza Vaccination Strategies Across Socioeconomically Disparate Regions in China.Vaccines (Basel)2026https://conductscience.org/library/papers/42188797PubMed
42089926From Trait-Structured Within-Host Dynamics to SIR Models: A Multiscale Framework With Re-Exposure.Bull Math Biol2026https://conductscience.org/library/papers/42089926PubMed
42078399Hemagglutination inhibition and alternate serologic responses following Influenza A(H3N2) virus infection.medRxiv2026https://conductscience.org/library/papers/42078399PubMed
41282858Controlled human influenza infection reveals heterogeneous expulsion of infectious virus into air.medRxiv2025https://conductscience.org/library/papers/41282858PubMed
40941331Dose-Dependent Porcine Deltacoronavirus Infection Reveals Linkage Between Infectious Dose and Immune Response.Animals (Basel)2025https://conductscience.org/library/papers/40941331PubMed
40748059Best Practices in the Development and Use of Experimental Models of Bacterial Pneumonia: An Official American Thoracic Society Workshop Report.Am J Respir Cell Mol Biol2025https://conductscience.org/library/papers/40748059PubMed
39589151Influenza virus infection and aerosol shedding kinetics in a controlled human infection model.J Virol2024https://conductscience.org/library/papers/39589151PubMed
39471873Reconciling founder variant multiplicity of HIV-1 infection with the rate of CD4+ decline.J R Soc Interface2024https://conductscience.org/library/papers/39471873PubMed
39093901Single-cell analysis of VACV infection reveals pathogen-driven timing of early and late phases and host-limited dynamics of virus production.PLoS Pathog2024https://conductscience.org/library/papers/39093901PubMed
39045688Symptom propagation in respiratory pathogens of public health concern: a review of the evidence.J R Soc Interface2024https://conductscience.org/library/papers/39045688PubMed
38701066Epidemiological and health economic implications of symptom propagation in respiratory pathogens: A mathematical modelling investigation.PLoS Comput Biol2024https://conductscience.org/library/papers/38701066PubMed
38063402Pan-antiviral effects of a PIKfyve inhibitor on respiratory virus infection in human nasal epithelium and mice.Antimicrob Agents Chemother2024https://conductscience.org/library/papers/38063402PubMed
37970627Propylene glycol inactivates respiratory viruses and prevents airborne transmission.EMBO Mol Med2023https://conductscience.org/library/papers/37970627PubMed
37732733Within-host diversity improves phylogenetic and transmission reconstruction of SARS-CoV-2 outbreaks.Elife2023https://conductscience.org/library/papers/37732733PubMed
36702771A Multicenter, Controlled Human Infection Study of Influenza A(H1N1)pdm09 in Healthy Adults.J Infect Dis2023https://conductscience.org/library/papers/36702771PubMed
36680215Risk Factors of Severe COVID-19: A Review of Host, Viral and Environmental Factors.Viruses2023https://conductscience.org/library/papers/36680215PubMed
36190270Viral load at hospitalization is an independent predictor of severe COVID-19.Eur J Clin Invest2023https://conductscience.org/library/papers/36190270PubMed

See all 49 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/30770534

GET https://conductscience.org/api/papers/v1/30770534/references?page=2